Simulation of corneal epithelial injuries by mechanical and corrosive damage: Influence of fetal bovine serum and dexpanthenol on epithelial regeneration in a cell culture model;Simulation von Korneaepithelverletzungen mittels mechanischer und korrosiver Schädigung: Beeinflussung der Regeneration durch fötales Kälberserum und Dexpanthenol am Zellkulturmodell

Ophthalmologe

Volumn 107, Issue 6, 2010, Pages 529-536

  Hahne, M ^a   Reichl, S ^a  

^a TECHNICAL UNIVERSITY OF BRAUNSCHWEIG   (Germany)

Author keywords

Cell culture; Corneal epithelium; Dexpanthenol; In vitro model; Wound healing

Indexed keywords

BOVINE SERUM ALBUMIN; DEXPANTHENOL; DODECYL SULFATE SODIUM; DRUG DERIVATIVE; PANTOTHENIC ACID; SURFACTANT;

ANIMAL; ARTICLE; CATTLE; CELL LINE; CELL SURVIVAL; CHEMICAL BURN; CORNEA EPITHELIUM; DRUG EFFECT; EPITHELIUM CELL; EYE BURN; FEMALE; HUMAN; IN VITRO STUDY; INJURY; MIDDLE AGED; PATHOLOGY; PH; REGENERATION;

ANIMALS; BURNS, CHEMICAL; CATTLE; CELL LINE; CELL SURVIVAL; EPITHELIAL CELLS; EPITHELIUM, CORNEAL; EYE BURNS; FEMALE; HUMANS; HYDROGEN-ION CONCENTRATION; MIDDLE AGED; PANTOTHENIC ACID; REGENERATION; SERUM ALBUMIN, BOVINE; SODIUM DODECYL SULFATE; SURFACE-ACTIVE AGENTS;

EID: 77954029784     PISSN: 0941293X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00347-009-2079-x     Document Type: Article

References (24)

1. Agrawal VB, Tsai RJF (2003) Corneal epithelial wound healing. Indian J Ophthalmol 51(2): 5-15.
2. Araki-Sasaki K, Ohashi Y, Sasabe T et al (1995) An SV40-immortalized human corneal epithelial cell line and its characterization. Invest Ophthalmol Vis Sci 36(3): 614-621.
3. Carrier P, Deschambeault A, Talbot M et al (2008) Characterization of wound reepithelialization using a new human tissue-engineered corneal wound healing model. Invest Ophthalmol Vis Sci 49(4): 1376-1385.
4. Cotsarelis G, Cheng SZ, Dong G et al (1989) Existence of slow-cycling limbal epithelial basal cells that can be preferentially stimulated to proliferate: Implications on epithelial stem cells. Cell 57(2): 201-209.
5. Davanger M, Evensen A (1971) Role of the pericorneal papillary structure in renewal of corneal epithelium. Nature 229(5286): 560-561.
6. Ebihara N, Funaki T, Murakami A et al (2005) Mast cell chymase decreases the barrier function and inhibits the migration of corneal epithelial cells. Curr Eye Res 30(12): 1061-1069.
7. Flueckiger F, Kodjikian L, Halberstadt M et al (2005) An ex-vivo, whole-globe porcine model of corneoepithelial wound healing tested using immunomodulatory drugs. J Ocul Pharmacol Ther 21(5)367-375.
8. Gehring W, Gloor M (2000) Effect of topically applied dexpanthenol on epidermal barrier function and stratum corneum hydration: Results of a human in vivo. Drug Res 50(7): 659-663.
9. Geerling G, Unterlauft JD, Kasper K et al (2008) Eigenserum und alternative Blutprodukte zur Behandlung von Augenoberflächenerkrankungen. Ophthalmologe 105(7): 623-631.
10. Göbbels M, Gross D (1996) Klinische Studie zur Wirksamkeit eines dexpanthenol-haltigen Tränenersatzmittels (Siccaprotect®) bei der Behandlung trockener Augen. Klin Monatsbl Augenheilkd 209(2-3): 84-88.
11. Harissi-Dagher M, Dohlman CH (2008) The Boston Keratoprosthesis in severe ocular trauma. Can J Ophthalmol 43(2): 165-169.
12. Haselmann G, Pufrich K, Haselmann H (1952) Zur Behandlung von Epithelschäden der Cornea. Ophthalmologe 6: 29.
13. Hennighausen U, Schmidt-Martens FW, Reim M (1972) Metabolitspiegel und Enzymaktivitäten des Energie liefernden Stoffwechsels im regenerierenden Corneaepithel. Ber Dtsch Ophthalmol Ges 71: 95-99.
14. Jumblatt M, Neufeld A (1986) A tissue culture assay of corneal epithelial wound closure. Invest Ophthalmol Vis Sci 27(1): 8-13.
15. Kehrl W, Sonnemann U, Dethlefsen U (2003) Advance in therapy of acute Rhinitis - Comparison of efficacy and safety of Xylometazoline in combination Xylometazoline-Dexpanthenol in patients with acute Rhinitis. Laryngorhinootologie 82(4): 266-271.
16. Liu L, Hartwig D, Harloff S et al (2005) An optimised protocol for the production of autologous serum eyedrops. Graefes Arch Clin Exp Ophthalmol 243(7): 706-714.
17. Petty RD, Sutherland LA, Hunter EM, Cree IA (1995) Comparison of MTT and ATP-based assays for the measurement of viable cell number. J Biolumin Chemilumin 10(1): 29-34.
18. Promega, Technical Bulletin, CellTiter-Glo® LuminescentCell Viability Assay.
19. Reza Mansouri M, Mirshahi A, Hosseini M (2007) Domestic ocular injuries: A case series. Eur J Ophthalmol 17(4): 654-659.
20. Rieck P, Pleyer U (2003) Wundheilung der Hornhaut. Teil II: Therapie von Wund-heilungsstörungen. Ophthalmologe 100(12): 1109-1130.
21. Rieck P, Sherif ZAR, Hartmann C, Pleyer U (2003) Wundheilung der Hornhaut. Teil I: Biologische Grundlagen und ihre Klinische Relevanz. Ophthalmologe 100(9): 749-770.
22. Tanelian D, Bisla K (1992) A new in vitro corneal preparation to study epithelial wound healing. Invest Ophthalmol Vis Sci 33(11): 3024-3028.
23. Tsubota K, Goto E, Shimmura S, Shimazaki J (1999) Treatment of persistent corneal epithelial defect by autologous serum application. Ophthalmology 106(10): 1984-1989.
24. Watanabe M, Kondo S, Mizuno K et al (2006) Promotion of corneal epithelial wound healing in vitro and in vivo by annexin A5. Invest Ophthalmol Vis Sci 47(5): 1862-1868.